NCT01454544View on ClinicalTrials.gov

A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet

PHASE3CompletedINTERVENTIONAL
Enrollment

992

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
House Dust Mite Allergy
Interventions
BIOLOGICAL

AIT Tablet

1 tablet per day in 12 months

Trial Locations (1)

34295

Department of Respiratory Diseases, Lapeyronie Hospital, Montpellier

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT01454544 - A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet | Biotech Hunter | Biotech Hunter